Evidence map›Paper›PMID 29365063›Full record

ArticleBrain : a journal of neurology2018

De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.

Andrew E Fry, Katherine A Fawcett, Nathanel Zelnik, Hongjie Yuan, Belinda A N Thompson, Lilach Shemer-Meiri, Thomas D Cushion, Hood Mugalaasi, David Sims, Neil Stoodley and 31 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Annals of the Child Neurology Society · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 7 countries.

Andrew E FryInstitute of Medical Genetics, University Hospital of Wales, Cardiff CF14 4XW, UK.
Katherine A FawcettMRC Computational Genomics Analysis and Training Programme (CGAT), MRC Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK.
Nathanel ZelnikPediatric Neurology Unit, Carmel Medical Center, Haifa, Israel.
Hongjie YuanDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Belinda A N ThompsonDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Lilach Shemer-MeiriPediatric Neurology Unit, Carmel Medical Center, Haifa, Israel.
Thomas D CushionDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Hood MugalaasiInstitute of Medical Genetics, University Hospital of Wales, Cardiff CF14 4XW, UK.
David SimsMRC Computational Genomics Analysis and Training Programme (CGAT), MRC Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK.
Neil StoodleyDepartment of Neuroradiology, North Bristol NHS Trust, Frenchay Hospital, Bristol BS16 1LE, UK.
Seo-Kyung ChungNeurology and Molecular Neuroscience Research, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA2 8PP, UK.
Mark I ReesNeurology and Molecular Neuroscience Research, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA2 8PP, UK.
Chirag V PatelGenetic Health Queensland, Royal Brisbane and Women's Hospital Campus, Herston, Brisbane, Queensland 4029, Australia.
Louise A BruetonWest Midlands Regional Genetics Service, Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
Valérie LayetService de Génétique Médicale, Groupe Hospitalier du Havre, Hôpital Jacques Monod, Le Havre, France.
Fabienne GiulianoService de Génétique Médicale, Centre Hospitalier Universitaire de Nice, Nice, France.
Michael P KerrMRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff CF24 4HQ, UK.
Ehud BanneClinical Genetics Institute, Kaplan Medical Centre, Rehovot, Israel.
Vardiella MeinerDepartment of Genetics and Metabolic Diseases, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
Tally Lerman-SagiePediatric Neurology Unit, Wolfson Medical Centre, Holon, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Katherine L HelbigDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Laura H KofmanKaiser Permanente Mid-Atlantic States, McLean, VA 22102, USA.
Kristin M KnightKaiser Permanente Mid-Atlantic States, McLean, VA 22102, USA.
Wenjuan ChenDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Varun KannanDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Chun HuDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hirofumi KusumotoDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jin ZhangDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sharon A SwangerDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Gil H ShaulskyDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ghayda M MirzaaDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Alison M MuirDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Heather C MeffordDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
William B DobynsDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Amanda B MackenzieDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Jonathan G L MullinsGenome and Structural Bioinformatics Group, Institute of Life Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
Johannes R LemkeInstitute of Human Genetics, University Medical Center Leipzig, Leipzig 04103, Germany.
Nadia Bahi-BuissonImagine Institute, INSERM UMR-1163, Laboratory Genetics and Embryology of Congenital Malformations, Paris Descartes University, Paris, France.
Stephen F TraynelisDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Heledd F IagoGenome and Structural Bioinformatics Group, Institute of Life Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
Daniela T PilzDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Emory University · USSwansea University · GBUniversity of Washington · USJohn Radcliffe Hospital · GBKaiser Permanente · USUniversity Hospital of Wales · GBUniversity of Bath · GBBirmingham Women's Hospital · GBCardiff University · GBCarmel Medical Center · ILCentral South University · CNCentre Hospitalier Universitaire de Nice · FRChildren's Hospital of Philadelphia · USGroupe Hospitalier du Havre · FRHebrew University of Jerusalem · ILInserm · FRKaplan Medical Center · ILLeipzig University · DENorth Bristol NHS Trust · GBQueen Elizabeth University Hospital · GB

Funding

Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
A Genomic Approach to EpilepsyR01NS069605 · NINDS · UNIVERSITY OF WASHINGTON · PI MEFFORD, HEATHER C. · 2010 to 2019
$4.9M
Control of Glutamate Receptor FunctionR01NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 1998 to 2018
$3.7M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted TherapyR01HD082373 · NICHD · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2015 to 2025
$3.3M
Functional effects of ion channel mutations found via exome sequencingR24NS092989 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2016 to 2019
$1.1M
Genes and pathways underlying brain overgrowth and focal cortical malformationsK08NS092898 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MIRZAA, GHAYDA · 2015 to 2019
$930k
Medical Research Council G0900747Medical Research Council G0900747 91070Medical Research Council MC_PC_15065NICHD NIH HHS R01 HD082373NICHD NIH HHS U54 HD083091NINDS NIH HHS K08 NS092898NINDS NIH HHS R01 NS036654NINDS NIH HHS R01 NS065371NINDS NIH HHS R01 NS069605NINDS NIH HHS R01 NS092772NINDS NIH HHS R24 NS092989Wellcome TrustWellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Polymicrogyria is a malformation of cortical development. The aetiology of polymicrogyria remains poorly understood. Using whole-exome sequencing we found de novo heterozygous missense GRIN1 mutations in 2 of 57 parent-offspring trios with polymicrogyria. We found nine further de novo missense GRIN1 mutations in additional cortical malformation patients. Shared features in the patients were extensive bilateral polymicrogyria associated with severe developmental delay, postnatal microcephaly, cortical visual impairment and intractable epilepsy. GRIN1 encodes GluN1, the essential subunit of the N-methyl-d-aspartate receptor. The polymicrogyria-associated GRIN1 mutations tended to cluster in the S2 region (part of the ligand-binding domain of GluN1) or the adjacent M3 helix. These regions are rarely mutated in the normal population or in GRIN1 patients without polymicrogyria. Using two-electrode and whole-cell voltage-clamp analysis, we showed that the polymicrogyria-associated GRIN1 mutations significantly alter the in vitro activity of the receptor. Three of the mutations increased agonist potency while one reduced proton inhibition of the receptor. These results are striking because previous GRIN1 mutations have generally caused loss of function, and because N-methyl-d-aspartate receptor agonists have been used for many years to generate animal models of polymicrogyria. Overall, our results expand the phenotypic spectrum associated with GRIN1 mutations and highlight the important role of N-methyl-d-aspartate receptor signalling in the pathogenesis of polymicrogyria.

Indexed as

AnimalsChildChild, PreschoolDNA Mutational AnalysisExcitatory Amino Acid AgonistsFamily HealthFemaleGlutamic AcidGlycineHEK293 CellsHumansInfantMagnetic Resonance ImagingMaleMembrane PotentialsModels, MolecularExcitatory Amino Acid AgonistsGlutamic AcidGlycineGRIN1 protein, humanNerve Tissue ProteinsN-MethylaspartateReceptors, N-Methyl-D-Aspartate

Identifiers

PMID29365063
PMCPMC5837214
OpenAlexW2788828922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.